Case 1:17-cv-00057-WYD-MEH Document 50-11 Filed 01/02/18 USDC Colorado Page 1 of 9 : i -- ;"""-.. . .~ . _ _) STATE OF COLORADO OFFICE OF ADMINISTRATIVE COURTS 1525 Sherman Street, 4th Floor Denver, Colorado 80202 BEFORE THE COLORADO MEDICAL BOARD: ;· t. · · ·-, • '·i- : -· · '. : • ' ~ . .• GARY WEISS, M.D. LICENSE NO. DR 25800, 4 ::~~ 'I • IN THE MATTER OF THE DISCIPLINARY PROCEEDING REGARDING THE LICENSE TO PRACTICE MEDICINE IN THE STATE OF COLORADO OF: ~~ . . ' ·• ! . . . . .. • • '4 COURT USE ONLY 4 CASE NUMBER ME 2014- Respondent. COMPLAINT, NOTICE OF DUTY TO ANSWER, NOTICE TO SET, NOTICE OF HEARING AND STATEMENT REGARDING OPTION TO ENGAGE IN ALTERJ\lATIVE DISPUTE RESOLUTION To: GARY WEISS, M.D. FORMAL COMPLAINT Inquiry Panel B of the Colorado Medical Board (the "Board") makes this Complaint against Gary Weiss, M.D. ("Respondent"), pursuant to section 12-3611 8(5 ), C.R.S. JURISDICTION AND THE PARTIES 1. Respondent is licensed to practice medicine in Colorado and holds license No. DR 25800. 2. The Board has jurisdiction over Respondent and the subject matter of these proceedings pursuant to sections 12-36-101 et seq. and 24-4-101 et seq., C.R.S. FACTUAL ALLEGTIONS 3. Patient A was an individual with multiple sclerosis ("MS") and a history of seizures. EXHIBIT L.t; 1 Exhibit 11 I 3 /J- I:; I I? Case 1:17-cv-00057-WYD-MEH Document 50-11 Filed 01/02/18 USDC Colorado Page 2 of 9 4. Patient A's MS escalated to secondary progressive MS after a 1996 automobile accident. 5. At all relevant times, there was no approved treatment for secondary progressive MS in the United States. 6. Between January 2009 and May 2009, Patient A was in and out of the hospital due to multiple infections and pneumonia. 7. A hospitalist recommended that Patient A be evaluated by Respondent. 8. Respondent is a neurologist, who at all relevant times treated patients in Gypsum, Colorado at Next Step Institute. 9. On May 7, 2009, Respondent examined Patient A and diagnosed her with relapsing and remitting MS with possible secondary progression. 10. At all relevant times, relapsing and remitting MS could be treated with the drug Tysabri. 11. Tysabri can prevent recurrent inflammation in patients with relapsing and remitting MS. 12. Tysabri can also cause a life threatening disease called progressive multifocalleukoencephalopathy ("PML"). 13. Tysabri was not approved for treatment of secondary progressive MS at the relevant time. 14. Respondent started Patient A on Tysabri in July 2009. 15. Respondent instructed Patient A to stop taking her seizure medications. 16. Respondent did not document what steps, if any, that he took to determine whether it was safe to take Patient A off her seizure medications. 2 Exhibit 11 Case 1:17-cv-00057-WYD-MEH Document 50-11 Filed 01/02/18 USDC Colorado Page 3 of 9 17. After she began Tysabri treatment, Patient A walked and swam for the first time in nine years. 18. On June 22, 20 I 0, Patient A complained of imbalance. 19. Respondent prescribed Ampyra, the so called "walking pill" for MS. 20. Ampyra should not be prescribed for patients with a history of seizures. 21. At the relevant time, Respondent, through Weiss Medical Associates, P.C., owned an MRI machine and interpreted his own MRI studies. 22. Respondent is not a radiologist. 23. Respondent is not board certified in neuroradiology. 24. In August 2010, Respondent ordered MRI studies of Patient A's brain. 25. Respondent interpreted Patient A's MRI studies and did not notice any new lesions on Patient A's brain. 26. In November 2010, a family member told Respondent that Patient A was more forgetful and acting differently. 27. By February 2011, Patient A had worsening gait, weakness in her right hand and right leg and had become dependent on a wheelchair. 28. Patient A had classic signs ofPML. 29. Respondent failed to recognize Patient A's PML signs. 30. Respondent ordered MRI studies of Patient A's brain in February 2011. 31. Respondent interpreted Patient A's MRI studies. 32. Respondent did not see evidence ofPML on Patient A's February 2011 MRI studies at the relevant time. 3 Exhibit 11 Case 1:17-cv-00057-WYD-MEH Document 50-11 Filed 01/02/18 USDC Colorado Page 4 of 9 33. At the relevant time, Respondent failed to appreciate a new brain lesion visible on Patient A's February 2011 MRI studies. 34. Patient A's February 2011 MRI studies were not interpreted by a radiologist. 35. Respondent continued Patient A's Tysabri treatment after the February 2011 MRI. 36. Thereafter, Respondent increased Patient A's Tysabri treatments to every 25 days. 37. By May 2011, Patient A's right sided weakness increased and she had slurred speech. 38. Respondent ordered MRI studies of Patient A's brain in May 2011. 39. Respondent interpreted Patient A's May 2011 MRI studies. 40. Respondent did not diagnose enhancing lesions or new lesions on Patient A's May 2011 MRI studies at the relevant time. 41. Respondent failed to appreciate a brain lesion shown on Patient A's May 2011 MRI that was more suspicious for PML. 42. Respondent continued Patient A's Tysabri treatment after the May 2011 MRI. 43. Patient A's May 2011 MRI studies were not interpreted by a radiologist. 44. By June 22, 2011, Patient A was struggling to speak and her family reported to Respondent a definite change in her cognition. 45. Respondent ordered another brain MRI in June 2011. 4 Exhibit 11 Case 1:17-cv-00057-WYD-MEH Document 50-11 Filed 01/02/18 USDC Colorado Page 5 of 9 46. Respondent interpreted the June 2011 MRI and noticed a lesion that was characteristic ofPML. 47. Patient A's care was transferred to the University of Colorado. 48. Patient A underwent plasma exchange to remove the Tysabri from her system. 49. Patient A was affected with right hemiplegia and aphasia. 50. Patient A died in September 2011. 51. Respondent now recognizes that there was a new lesion on Patient A's February 2011 MRI stndies that was the start ofPML. COUNT I UNPROFESSIONAL CONDUCT (Violation of Colo. Rev. Stat. §12-36-117(1 )(p) - substandard care) 52. The Board incorporates by reference the allegations contained in Paragraphs 1-51 as if fully set forth herein. 53. Respondent failed to meet the generally accepted standard of medical practice in his care and treatment of Patient A and, therefore committed unprofessional conduct pursuant to Colo. Rev. Stat.§ 12-36-117(1)(p), by one or more of the following: a. mis-diagnosing Patient A; b. treating Patient A with Tysabri; c. continuing to treat Patient A with Tysabri after there were signs that it was not effective; d. continuing to treat Patient A with Tysabri after there were signs of PML; e. failing to properly monitor Patient A's neurological status; 5 Exhibit 11 Case 1:17-cv-00057-WYD-MEH Document 50-11 Filed 01/02/18 USDC Colorado Page 6 of 9 f. prescribing Ampyra to Patient A; g. misinterpreting Patient A's MR!s; h. failing to interpret Patient A's MRis based on clinical context; i. failing to have Patient A's MRls read by a radiologist or neuroradiologist; j. failing to compare MRI studies with prior MRI studies to assess for interval change; k. ordering improper interval studies; 1. failing to order an EEG before prescribing Ampyra m. unqualified interpretation ofMRI studies; n. prescribing Tysabri more frequently than recommended; and o. failing to recognize brain lesions on Patient A's MRis. COUNT II UNPROFESSIONAL CONDUCT (Violation of Colo. Rev. Stat. §12-36-117(I)(cc) - substandard care) 54. The Board incorporates by reference the allegations contained in Paragraphs 1-53 as if fully set forth herein. 55. Accurately documenting the physical and mental status of a patient being treated with Tysabri are essential entries in a patient's medical record. 56. Documenting considerations and impressions ofMRis are essential entries in medical records 57. Respondent repeatedly failed to make essential entries in Patient A's medical records, in violation of Colo. Rev. Stat. § 12-36-117(1 )( cc), by one or more of the following: 6 Exhibit 11 Case 1:17-cv-00057-WYD-MEH Document 50-11 Filed 01/02/18 USDC Colorado Page 7 of 9 a. Failing to provide quantitative documentation of Patient A's mental status when there were concerns of her mental status; b. Failing to document the steps, if any, that he took to determine whether it was safe to take Patient A off her seizure medications; c. Failing to document a clear picture of Patient A's MS before prescribing Tysabri; d. Failing to document his impression of each MRI study; e. Failing to document whether he compared MRI studies with prior MRI studies; f Failing to document a complete health history for Patient A; g. Failing to keep a copy of all MRI images in his medical chart; and h. The subjective assessment of Respondent's medical records on the dates ofJune 16, 2011, March 9, 2011, April 13, 2011, May 4, 2011 and May 11, 20 11 contradict the information contained in the Gait & Station section of the same medical reports. 58. Falsifying or repeatedly making incorrect essential entries or repeatedly failing to make essential entries on patient records is unprofessional conduct within the meaning of Colo. Rev. Stat.§ 12-36-117(1)(cc). WHEREFORE, the Board respectfully requests that an administrative law judge discipline Respondent's license to practice medicine in the State of Colorado, as provided by law. 7 Exhibit 11 Case 1:17-cv-00057-WYD-MEH Document 50-11 Filed 01/02/18 USDC Colorado Page 8 of 9 NOTICE OF DUTY TO ANSWER YOU ARE HEREBY NOTIFIED that, pursuant to Colo. Rev. Stat.§ 24-4-104(2), you are required to file a written answer to this Complaint, Notice of Duty to Answer, Notice to Set, Notice of Hearing and Statement Regarding Option to Engage in Alternative Dispute Resolution ("Complaint") with the Office of Administrative Courts, 1525 Sherman Street, 4'h Floor, Denver, CO 80203, within 30 days after the mailing of this Complaint. You must also mail a copy of such answer to the attorney for the Panel, Allison Ailer, Assistant Attorney General, Office of the Attorney General, Ralph Carr Judicial Center, 1300 Broadway, gth Floor, Denver, CO 80203. If you fail to file your written answer within 30 days, an order entering a default decision may be issued against your Colorado medical license for the relief requested in the Complaint or such other penalties which may be provided for by law without further notice. NOTICE TO SET YOU ARE HEREBY NOTIFIED that an attorney for the Panel will appear in person or by telephone at 11:15 a.m. on April25, 2014, in the Office of the Director for the Office of Administrative Courts, 1525 Sherman St., 4th Floor, Denver, CO 80203, to set a date and obtain a location for a hearing regarding the Complaint. You may be present in person or by counsel, or you may make prior arrangements to be reached by telephone at the time and date specified above by contacting the setting clerk prior to the day of setting at (303) 866-5797. If you fail to appear, a date will be obtained and you will be notified in writing of the hearing date, time and place. 8 Exhibit 11 Case 1:17-cv-00057-WYD-MEH Document 50-11 Filed 01/02/18 USDC Colorado Page 9 of 9 NOTICE OF HEARING YOU ARE HEREBY NOTIFIED, that pursuant to Sections 12-36-118, 24-4-104 and 24-4-105, C.R.S., a hearing will be held before an authorized administrative law judge pursuant to the Complaint for the purpose of detennining whether you engaged in unprofessional conduct as set forth in section 12-36-117(1 )(p), C.R.S. of the Colorado Medical Practice Act and whether your license to practice medicine in Colorado should be disciplined pursuant to section 12-36-118(5), C.R.S. YOU ARE FURTHER NOTIFIED that at the hearing in this matter, you shall have the right to appear in person and/or by legal counsel, to present evidence on your own behalf, to cross-examine any witnesses presented by the Board and to rebut any evidence presented by the Board. You may also have subpoenas issued on your behalf upon request to the administrative law judge. Respectfully submitted this 19th day of March, 2014. JOHN W. SUTHERS Attorney General /J: ---~-ll ~ 4/~J.---- ~~--e d L SON R. AlLER, 33008* Assistant Attorney General Medical Board Unit Business & Licensing Section Attorneys for Panel A Ralph L. Carr Colorado Judicial Center 1300 Broadway, 8th Floor Denver, Colorado 80203 Telephone: 720-508-6392 Email: Allison.Ailer@state.co.us *Counsel of Record 9 Exhibit 11